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Abstract
Background: As the problem of patient non-adherence persists and a solution appears hard to
be found, it continues to be important to look for new ways to further the issue. We recently
conducted a meta-review of adherence intervention studies which yielded a preliminary agenda for
future research, practice and theory development in patient adherence. The objective of the
present project was to find out to what extent adherence experts consider this agenda relevant
and feasible.
Methods: The thirty-five corresponding authors of the review studies included in the meta-review
were invited to join the International Expert Forum on Patient Adherence and to participate in a
four-week web-based focus group discussion. The discussion was triggered by the points on the
preliminary agenda presented as propositions to which forum members could react. Two
researchers analysed the transcripts and selected relevant phrases.
Results: Twenty adherence experts participated. Various ideas and viewpoints were raised. After
the closure of the web-site, the expert forum was asked to authorize the synthesis of the
discussion, to list the propositions in order of priority and to answer a few questions on the use
of the web-based focus group as a tool to obtain expert opinions. Their ranking showed that the
development of simple interventions is the most promising step to take in fostering patient
adherence, preferably within a multidisciplinary setting of medical, pharmaceutical, social and
technical science and, not in the least, by incorporating patients' perspectives.
Conclusion: For enhancing adherence, the development of simple interventions originating from
a multidisciplinary perspective including patients' input, appears most promising. Disclosing
patients' perspectives requires open communication about patients' expectations, needs and
experiences in taking medication and about what might help them to become and remain adherent.
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Background
Not taking medication as prescribed – taking either too lit-
tle, or too much, for too short, or too long a period, at the
wrong time or in an ineffective way – can have negative
consequences for patients, healthcare and economy [1].
This non-adherence problem grows even more important
as the burden of chronic diseases is growing worldwide
[1]. Due to the scale of the problem it has been claimed
that studies examining the effectiveness of adherence
interventions should have priority over studies on new
medical treatments [2]. Numerous interventions have
been developed and implemented but the problem of
non-adherence appears difficult to solve [3]. Given the
weak theoretical underpinning of many adherence inter-
ventions, a fruitful step might be to find the most promis-
ing theoretical mainstreams.
Mindful of this aim we recently conducted a meta-review
of high quality papers on patient adherence with the aim
of identifying theoretical perspectives in successful adher-
ence interventions [4]. In short, the meta-review revealed
that most interventions are eclectic in nature and not
strictly representative of one theoretical mainstream. In
addition, there are effective adherence interventions, e.g.
technical solutions, without an explicit theoretical expla-
nation of the operating mechanisms; effective adherence
interventions, e.g. incentives and reminders, which clearly
originate from behavioral theories; theories which seem
plausible for explaining but less powerful in improving
adherence behavior; and a scarcity of comparative studies
explicitly contrasting theoretical models or their compo-
nents. These conclusions were summarized in six proposi-
tions reflecting a potential research agenda for future
directions in research and theory development in patient
adherence. The next step in furthering patient adherence
was to find out how experts in the field valued the agenda,
first by inquiring about each expert's current opinion of
the agenda and the viewpoints being put forward by other
experts, and next about the priority they would assign to
the different points on the research agenda. The experts
were asked to participate in a focus group discussion. In
this position paper we present the synthesis of this discus-
sion which was authorised by all participating experts
and, subsequently, their priority assignments. In addition,
the participants were asked to complete some questions




All thirtyfive corresponding authors of the review papers
included in our recent meta-review on patient adherence
[4] were invited to join the International Expert Forum on
Patient Adherence and to give, in that capacity, their
expert opinion on the future of research and theory devel-
opment in patient adherence by participating in an Inter-
net discussion. Initially, 25 review authors indicated their
willingness to participate and of these, 20 actually did find
time to do so.
Internet forum discussion
The experts were approached by means of a focus group
discussion triggered by the six propositions which
resulted from the meta-review. Focus groups are often
used to generate opinions and ideas about a specific topic
[5]. Given the international character of adherence-
research, Internet group discussions were held. The pro-
posed methodology allows participants to join discus-
sions in a rapid and convenient manner and evades
logistic problems such as distance and transport. So, there
are no time nor place constraints to join the focus group.
In addition, in comparison with face-to-face group discus-
sions, a web-based discussion has the advantage that par-
ticipants feel free to present whatever information [6].
Procedure
After small-scale pilot testing, a web-based focus group
discussion was organized in the beginning of 2006. As a
first step in the discussion, every member of the Interna-
tional Expert Forum received a private login-number to
access the closed-circuit website. Participants were invited
to login and react to the propositions offered and to con-
tribute actively to the discussion that gradually unfolded.
Firstly, the expert forum members were asked whether or
not they endorsed the given proposition (Table 1) which
was briefly explained (See Additional file 1) and, sec-
ondly, to clarify their opinion and react to the points
made by others. In a second round, the different view-
points and ideas were synthesized and the experts were
asked to authorize the synthesis and to prioritize the prop-
ositions on importance ranging from 1 (relatively unim-
portant) to 5 (extremely important). The website was
open for 4 weeks, 24 hours a day. The technological infra-
structure of the website was developed within a study on
communication and role delineation in paediatric oncol-
ogy [7,8]. All participants responded using their full
name.
As the forum members were free to bring in whatever they
wanted to the discussion, not every expert reacted to every
proposition. The number of them who did is shown in
Table 1. After the closure of the website, key arguments
within each expert's reactions were selected. Two authors
(ES and SvD) each read the transcripts and highligthed
essential elements. Disagreements were discussed until
consensus was reached about what to include in the syn-
thesis. The forum discussion was triggered by the proposi-
tions that resulted from our meta-review [4]. For that
reason, the propositions, and not the key arguments or
topics raised, were used to structure the results describedBMC Health Services Research 2008, 8:47 http://www.biomedcentral.com/1472-6963/8/47
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in this paper. As the experts may have presented a similar
argument in response to different propositions, some
doubling of information is inevitable. It was decided not
to delete every overlapping phrase, because we thought it
to be important to stay close to the experts' line of reason-
ing and wanted to show that some solutions, e.g. the
importance of doctor-patient communication in case of
reaching and maintaining adherence, were mentioned as
being relevant in response to different propositions. In the
last section, the overall key aspects are presented and dis-
cussed. The synthesis of the Internet forum discussion pre-
sented below includes the arguments mentioned either in
favour of or against the proposition by the participating
experts. Similar arguments mentioned by different experts
are grouped and counted, individual remarks are marked
by the expert's initials.
Results
Synthesis of Internet discussions
Simple interventions
The first proposition the forum members were asked to
react to was: "Focus on simple interventions workable and
feasible in (busy) clinical practice". Simple and down-to-
earth interventions are badly needed, because "if the inter-
vention is more complex than the problem, it has poor
chances of offering a solution (MI)". The experts further-
more argue that the regimens patients nowadays have to
follow are becoming increasingly complex, time-consum-
ing and costly, "for example as a result of co-morbidity
especially in the chronically ill (MvdW)". "The growing
complexity merely points at the lack of understanding of
adherence (EV)". Interventions should not only be simple
for the professional but for the patient also (LT). In the
experts' viewpoint, technical approaches should be used
wherever possible, for example telephone reminders
(MvE). These may reduce clinical load over time (JC).
Nine experts think that usual care should be improved, for
instance "by upskilling clinicians (JC)". The reason they
give for this is that good communication and collabora-
tion is "free" – except for the required additional time and
effort – fits within daily clinical practice and should
already be part of any clinicians' basic practice (MW). It is
thereby considered to be important to "look at the exist-
ing trade-offs between effectiveness and costs (e.g. mone-
tary, time, effort, etc.) both for the service provider and the
patients (AG)". "In the field of mental health simple strat-
egies, such as meeting the outpatient staff before hospital
discharge, may improve adherence (CB)". Addressing
adherence must be a routine part of the visit, just like tak-
ing blood pressure (LT). "We need a framework in our
healthcare system to address adherence as we do with
referring a patient to a specialist, or sending a patient to
get blood work done. The assessment of adherence should
be expected by the patient as well as the physician (LT)".
The experts add to this that improvements of adherence
should not only be part of the physicians' work, but
should be the work of a multidisciplinary team. They state
that there will always be patients who require more inten-
sive (and expensive) guidance and support. Therefore, the
experts consider it particularly important to identify sub-
optimal adherence in the earliest stages. Predictors of
non-adherence and screening tools to identify groups at
risk for non-adherence are therefore highly needed.
Conjoint efforts
In response to the second proposition "Progress in adher-
ence theories is to be expected from conjoint efforts of
medical, pharmaceutical, social and technical scientists"
fifteen out of the 20 experts argue that a multidisciplinary
approach of the adherence problem is vital and definitely
the way forward. "Technology plays a large role in
improving adherence by designing simpler and more
effective treatments with fewer behavioral demands and
fewer adverse effects. In addition, human engineering and
ergonomics might provide manufacturers with guidance
concerning dosing, packaging and scheduling treatments
Table 1: Number of experts1 agreeing with each meta-review proposition and the priority scores assigned by 18 of the 20 participating 
experts listed from high to low
Meta-review propositions Agree N Partly agree N Disagree N Priority score2 Mean (sd)
1 Focus on simple interventions workable and feasible in (busy) clinical 
practice
12 5 0 2.7 (1.2)
2 Progress in adherence theories is to be expected from conjoint efforts of 
medical, pharmaceutical, social and technical scientists
11 5 1 3.29 (1.8)
3 Patient groups should (help to) develop adherence interventions 16 0 0 3.35 (1.5)
4 Adherence interventions should be limited solely to non-adherent patients 2 6 10 3.35 (1.9)
5 Current adherence theories are more successful in explaining than in 
improving adherence: theory development should focus on improving 
adherence
5 4 8 3.65 (1.8)
6 To improve adherence, changing the situation is more promising than 
changing the patient
4 12 2 4.5 (1.5)
1 Not every expert reacted to every proposition
2 Range 1 – 6; 1 indicating highest priority, 6 lowest priorityBMC Health Services Research 2008, 8:47 http://www.biomedcentral.com/1472-6963/8/47
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(BH)". Five experts believe that technical solutions or
innovations may provide universal interventions that
remove barriers for all. In their opinion, new technologies
can support healthcare providers to monitor (non-)adher-
ence and provide opportunities to discuss it with the
patient. However, nearly all experts also argue that techni-
cal solutions are "just one part of the puzzle (LT)". Psy-
chosocial issues must be addressed as well because "the
main hurdles to adherence remain behavioral and
humanistic in nature (MI)". Many more factors are
involved in adherence: healthcare providers, systems of
care, treatment modalities, social environment and so on
(TV). Asking about adherence in a non-threatening man-
ner and monitoring it should be universally adopted (JC).
One way to do so is by discussing possible treatment
choices with the patient and the logic behind them (AY).
The experts believe that it is more often the psychological
variables that will ultimately determine lasting change.
Four experts bring forward that technical solutions may
differ between clinical areas. In mental healthcare, the
emphasis is on psychotherapeutic strategies, such as the
application of motivational strategies, which have shown
at least some effect in improving adherence. Special atten-
tion should be given to, for example, vulnerable elderly
people (MvE). In some clinical areas – for example type 2
diabetes care – biotechnical solutions are not immediately
at hand. The emphasis is on the motivational and per-
sonal side of persons living with (such) health problems
to support and empower them (HvD).
Patient groups
All sixteen experts that responded to the third proposition
"Patient groups should (help to) develop adherence inter-
ventions" agree unanimously that focusing on patients is
crucial to improve adherence. They feel that time has
come to consult individual patients or patient groups
about their needs and wishes in relation to adherence.
Patients or patient groups should help develop adherence
interventions. One of the experts argues that, "for too
long, we have tried to squeeze clinical populations into
our existing models. Patients should be informing our
models. This will surely lead to the most environmentally
valid theories and solutions (MW)". In addition, it is
important to inquire about the patients' reasons for non-
adherence (TV) and the barriers to adherence (MvdW).
Besides, certain interventions developed by certain patient
groups may only be effective in a certain population (LT).
Therefore, many different patient populations should be
consulted and represented: patients from different back-
grounds, age, gender and other socio-demographic char-
acteristics (KS).
Another idea would be to let experienced patients help
healthcare providers with their own 'tips and tricks' that
helped them to adhere (MvdW). The experts furthermore
argue that there is much we already know about what
patients want. Patients who forget want simplified regi-
mens and a reminder system, patients who get side effects
want them to disappear, and patients who think the med-
ication won' t help, don't want to take them after all (JC).
Increasingly, reasons for non-adherence are being dis-
cussed, but so far adherence interventions are seldom tai-
lored to the patients' wishes. Perhaps the best way to
proceed concerns the adherence-experiences of the profes-
sionals themselves. Most of them have experienced
(adherence to) self-administered treatments. Perhaps we
should require the treatment developers to take the treat-
ment (or facsimile/placebo) themselves for a period of
time (BH).
Non-adherent patients
Because of the complexity of identifying non-adherent
patients, many experts disagree with the fourth proposi-
tion that "Adherence interventions should be limited
solely to non-adherent patients". Although the experts do
acknowledge that it is more efficient and affordable to
focus on patients who need help, it is their opinion that
providers cannot reliably distinguish adherent from non-
adherent patients. One reason they give for this is that,
due to the weak correlation between adherence and out-
come, failed clinical progress is not a reliable indicator
(BH). In addition, it is as yet unknown how much adher-
ence is enough. "For certain drugs, sticking closely to the
treatment regimen is very important, whereas for others
the timing and frequency of dose taking may be much less
crucial to achieve the desired treatment effect (KS)" Seven
of the experts argue that there is not a clear distinction
between adherent and non-adherent patients: it is a con-
tinuum. Four experts also mention that adherence fluctu-
ates over time, so "adherent patients are also at risk of
becoming non-adherent down the line (MI)". This indi-
cates that one must also pay attention to the prevention of
non-adherence (MvE), for instance by increasing patients'
knowledge about disease and treatment (LM).
According to some experts, a distinction can be made
between interventions which should be universally
applied, for example technical solutions, and more indi-
vidually tailored interventions. Especially for long term
regimens, it remains important to put adherence perma-
nently on the agenda of the doctor, even if the patient
seems to be adherent (MvdW). Adherent patients should
not be ignored (MI). Eight experts point to the importance
of the doctor-patient communication in adherence. They
consider communication "an essential piece of this puzzle
(KH)". Respect for the patient and collaborative treatment
goals are services which have no financial costs attached
and should anyway be part of basic clinical practice
(MW). Four experts add to this that the communication
requires patients to feel comfortable discussing with theirBMC Health Services Research 2008, 8:47 http://www.biomedcentral.com/1472-6963/8/47
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providers difficulties they may be having with a regimen,
so that the regimens can be modified as needed. There-
fore, the clinicians' awareness and practice of monitoring
non-adherence should be improved (JC).
Improving adherence
Eight experts disagree with the fifth proposition that "Cur-
rent adherence theories are more successful in explaining
than in improving adherence: theory development should
focus on improving adherence". They notice that as yet
there is hardly a sound theoretical basis for explaining
adherence behaviour. Besides, five experts argue that
adherence theories hardly explain the variance in adher-
ence. They don't see "great strides forward in this area
(DR)". More than half the group of experts agree that most
current adherence interventions are not very successful in
improving adherence either. They do acknowledge that
there are a number of theories and constructs that have
furthered our understanding of, for example, the cognitive
processes underlying (non-)adherence (MW). However,
the many theories have not led to efficacious standard
interventions improving adherence nor necessarily trans-
late directly into easy implementable effective clinical
strategies (LM). So far, "researchers are only scratching the
surface and shaking their heads at how complex adher-
ence behavior really is (DR)". What is more, a lot of theo-
ries focus on cognitive processes but not on barriers
(MvE). Six experts raise the issue that non-adherence is a
complex phenomenon and that it is in general "notori-
ously difficult to change health behaviour (NB)". Non-
adherence may have many different causes. The factors
and barriers vary between patients or patient groups in
different situations and there are many differences at indi-
vidual level (MvE). Besides, many forms of non-adher-
ence exist (LM). There is, for example, a significant
distinction between intentional non-adherence (actively
deciding not to follow prescriber's recommendations)
and unintentional or non-planned non-adherence [9],
which is not even considered in most theories (ED). These
different forms of non-adherence require corresponding
situation-specific interventions and an individually tai-
lored approach (ED).
Seven experts state that theories are needed to understand
the non-adherence phenomenon and interventions
should be based on findings from theories explaining
adherence. They, however, do acknowledge "the danger of
re-focusing research efforts on purely intervention based
theory, without in first instance fully understanding the
primary problem (MW)". Ideally, there should be a two-
way interaction between the development of theories and
effective interventions (MvE).
With respect to the focus of future theory development,
the following items were mentioned by more than three
experts: Different forms of non-adherence; physician-
patient communication; individual's specific adherence
problems and perspectives. Three experts would encour-
age a more fundamental shift in focus. "Non-adherence
should not be conceptualized as analogous to a pathology
within the patient, and therefore needing to be 'cured'
(NB)". Questions they would like to be answered include:
What do patients want from healthcare and how well does
professional care respond to this patients' perspective? To
what extent does professional care really support and
empower patients to find their way in healthcare, in self-
care and in life? Finally, the experts ask for better studies
and developing standardized definitions of adherence
and reliable measurement instruments, together with con-
ducting more multidisciplinary studies and well con-
ducted qualitative studies for a better understanding of
adherence. And, "the gap between behavioral science and
biomedicine should be bridged (TV)".
Change the situation
Some experts argue that it may be too early to agree to the
sixth and last proposition that "To improve adherence,
changing the situation is more promising than changing
the patient". So far, neither (interventions) are doing very
well and it is necessary to change both patient and envi-
ronment (BH). This can, for instance, be done by provid-
ing equipment that makes it more easy to take medication
or by strengthening patients' motivation to use their med-
ication in a proper way, respectively. One of the experts
remarks: " 'What makes it easier for patients to adhere' is
a good starting point, but by itself it is unlikely to be suf-
ficient to assure adherence. Those patients at high risk of
nonadherence due to other factors, e.g. 'can't afford it',
'too many side effects', and those not inclined may need
additional interventions or a change in the prescription
(ED)".
The experts furthermore argue that technology has much
to offer regarding the manipulation of the environment
and other treatment factors. Reducing technical and envi-
ronmental barriers to adherence is important, but some
patients need additional measures. Psychological varia-
bles have been shown to be of at least equal importance
in adherent behaviour which indicates that there is a place
for behavioral and educational interventions (MW).
"Technical solutions apply more universally whereas psy-
chological factors are more individual and require indi-
vidual assessment and targeting (LM)". In addition, at the
population level, characteristics of the healthcare system
may affect adherence (the way clinicians are trained, pack-
aging or dosage regimen, costs). These causes need to be
approached at system level (JC). At an individual level
contributing causes vary between groups and individuals.
Five experts argue that it is important to distinguish pat-
terns or types of non-adherence to tailor interventions; forBMC Health Services Research 2008, 8:47 http://www.biomedcentral.com/1472-6963/8/47
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some patients, non-adherence is a rational choice, some
may benefit from removing (situational) barriers and oth-
ers need to be educated.
A number of experts address the provider. They argue that
from the patients' point of view, "changing the situation
may need to include changing the prescriber's behaviour
(JC)". Prescribers should discuss (non-)adherence more
openly with their patients and ask patients about adher-
ence routinely (JC). "It is also important that health care
providers change their own behavior to discuss this sub-
ject more open with the patient (MvdW)". Changing the
situation also includes considering changing treatment
guidelines, because "it may be more realistic to adjust
treatment to the patient than to adjust the patient to the
treatment (BB)".
Prioritization of the propositions
Eighteen of the 20 experts that participated in the forum
discussion prioritized one or more of the six propositions
about the future of research and theory development in
patient adherence which had formed the basis of the
forum discussion (Table 1). The highest mean priority
score was assigned to the effort that has to be put in
exploring and developing simple interventions that can
be easily implemented in everyday practice. The second
highest priority was assigned to joining the knowledge of
medical, pharmaceutical, social and technical sciences for
enhancing adherence research and practice. Priority
number three indicates that many experts believed that it
is important to include patient perspectives in developing
adherence interventions. Asking patients what could help
them to become more adherent and tailoring interven-
tions to these patients' wishes could be important steps to
accomplish this objective. Limiting interventions to non-
adherent patients only or focusing more on improving
than explaining adherence scored a lower priority rank-
ing. Finally, changing situational factors had the lowest
priority for the experts. Not that environmental factors are
considered irrelevant, but, according to the experts,
because solely focusing on these factors engenders the risk
of overlooking relevant patient-related (psychosocial) fac-
tors. An open eye to all contributing factors is warranted
by most.
Overall, the priority rankings did not coincide completely
with the extent to which the experts agreed to the propo-
sitions (Table 1). For instance, the proposition to which
most experts disagreed, i.e. to apply adherence interven-
tions solely to non-adherent patients, did not receive the
lowest priority ranking. Likewise, the proposition related
to initiating conjoint efforts was agreed upon by less
experts than the proposition about including patient
groups for developing interventions, yet did receive a
higher priority ranking. This suggests that our way of gath-
ering data allowed to distinguish between eliciting expert
opinions about certain adherence-related themes and
their viewpoints about what is needed to move adherence
research, practice and theory a step further.
Evaluation of the Internet expert forum discussion
The experts completed a few questions about the use of
the Internet for obtaining insight into the state-of-the-art
in patient adherence (Table 2). On the question how they
experienced the use of the web-based discussion as a way
to dig up international expert opinions, 15 of the 18
experts (83%) who answered this question replied that it
was better than using an individual written format, one
said it was better than face-to-face discussions, while two
disagreed on the latter. An answer on the open question
revealed that the Internet forum was considered "...an eco-
nomic way of exchanging views on a subject in search of
consensus". Most experts (76%) indicated that they
accessed the website more than once. Twelve experts
(71%) said that they reacted to other experts' comments
in one or two of the six propositions, four experts (24%)
did not react to others at all and one said to have reacted
to other experts' comments in most propositions.
Although the experts were asked to participate actively in
the discussion, a real interaction may have to be stimu-
lated somewhat more. As one of the experts remarked: "I
don't think that they can replace face-to-face discussions –
but it is useful for gathering information for future discus-
sions". Someone else said: "I think it would be useful to
explore ways to obtain more interaction among partici-
pants. A different structure of the discussion could
improve the interaction and exchange of opinions among
participants". Finally, the experts were asked how they
had experienced the amount of time (4 weeks) to enter
their comments on the Internet forum. Fifteen respond-
ents (88%) answered that it was enough. Most proposi-
tions actually generated a considerable spread in answers
of people either agreeing or disagreeing with a certain
proposition.
Discussion
This position paper presented experts'opinions about the
steps that need to be taken for furthering patient adher-
ence. The development of simple interventions seems the
most promising, preferably within a multidisciplinary set-
ting of medical, pharmaceutical, social and technical sci-
ence and, not in the least, by incorporating patients'
perspectives.
Patient adherence is the outcome of a process in which
many people are involved. This multifaceted character of
adherence might explain why many experts agreed in join-
ing the knowledge of medical, pharmaceutical, social and
technical sciences for enhancing adherence research and
practice. To quote one of the experts: "Medicine and phar-BMC Health Services Research 2008, 8:47 http://www.biomedcentral.com/1472-6963/8/47
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macy research and development identify new treatments;
social science theories identify barriers to use the new
treatments (i.e. explain non-adherence) and; technical sci-
ences (e.g. ergonomics, human engineering) are impor-
tant tools to remove such barriers and improve use of and
adherence to the new treatments (AG)". Surprisingly, the
potential for joint interventions at different levels, e.g.
organizational, clinician and patient, is not mentioned by
any of the experts, although this is a common approach to
quality improvement in many healthcare settings.
The theoretical underpinning of developing simple inter-
ventions – priority number one in the eyes of the experts
– is not straightforward. From a cognitive theoretical
point of view, simpler regimes may simply be recalled bet-
ter or, following economical cost-benefit principles, cause
less discomfort. Within this line of research and practice
biomedical models, behavioral theories as well as educa-
tional perspectives seem to come to the fore [4]. Yet, so far
it has hardly been examined what specific elements
underlying each theoretical perspective account for the
most effectiveness.
The experts furthermore stress the importance of making
the assessment of adherence routine business in clinical
practice. This asks for the development of effective com-
munication strategies that can be applied in discussing
medication use and patient adherence in a non-threaten-
ing and open way. Identifying missed opportunities and
best practices could be the first step. Another way could be
to listen to what the patients themselves consider worth-
while interventions. After all, the meaning of 'simple' in
relation to adherence interventions can only be deci-
phered by listening to the patient. Patients are the experts
when trying to establish what constitutes a simple inter-
vention, e.g. as being not too intrusive or invasive nor
time-consuming or costly.
Conclusion
For enhancing adherence, the development of simple
interventions, a multidisciplinary perspective as well as
the use of patients' input appear most promising. Eliciting
patients' perspectives requires an open discussion of
patients' expectations, needs and experiences in taking
medication by the care providers involved and to pay
attention to what patients might help to become and
remain adherent. This is just as much a challenge for
patients as it is for health professionals.
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Table 2: Evaluation questionnaire about the Internet forum discussion
For the purpose of evaluating the applied web-based method of raising expert opinions, please complete the following questions.
1. Did you participate in the Internet forum discussion?
 No
 Yes, I accessed the website once to enter my comments
 Yes, I accessed the website more than once to enter my comments
2. Did you react on the comments put forward by other forum members?
 No
 Yes, in one or two propositions
 Yes, in every proposition I reacted upon
3. How did you experience the use of this web-based discussion as a way to dig up international expert opinions?
 No better than using an individual written format
 No better than a face to face discussion
 Better than using an individual written format
 Better than a face to face discussion




5. How did you value the instructions on the website?
 Clear and understandable
 Need some improvements
 Difficult to understand
6. Do you have any comments that could help us in planning future web-based discussions?
...............................................................................................................
...............................................................................................................
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